Viatrexx Ki-Diab: Incorrect medicinal ingredient
Brand(s)
Last updated
Summary
Product
Viatrexx Ki-Diab
Issue
Health products - Product quality
What to do
Consult your healthcare provider for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
|---|---|---|---|---|---|
Viatrexx Ki-Diab |
Viatrexx Ki-Diab |
NPN 80059881 |
Oral Spray |
Adenosine cyclic-3',5'-(hydrophosphate) 30K, Alpha-Ketoglutaric Acid 6X, 30K, Conium maculatum 30K, Lipoic acid 6X, 30K, Silice 30K |
Lot: 21-0127 |
Issue
Affected lot contains the medicinal ingredient adenosine triphosphate instead of adenosine cyclic-3',5'-(hydrophosphate).
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Viatrexx (8046255 Canada Inc)
1360 Louis-Marchand
Beloeil, QC
J3G 6S3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-75290
Get notified
Receive notifications for new and updated recalls and alerts by category.